Opinion

Video

Kara Cossis, PA-C, MPH, on the role of APPs in genetic testing

Key Takeaways

  • Advanced practice providers are key in educating patients about genetic testing for prostate cancer and its implications for treatment.
  • APPs interpret genetic test results and guide treatment decisions, either within their practice or through referrals to oncology partners.
SHOW MORE

APPs can help in introducing genetic testing and in the interpretation of results, according to Kara Cossis, PA-C, MPH.

In this video, Kara Cossis, PA-C, MPH, discusses the role of advanced practice providers (APPs) in expanding and encouraging the use of genetic testing for prostate cancer. Cossis is a physician assistant at Chesapeake Urology in Towson, Maryland.

Video Transcript:

I think there's a very good role for APPs to introduce the genetic testing to the patients to help explain what exactly we're testing for, why we're testing for it, what it means potentially for their cancer treatments. And then, as the results come back, to be able to review the results with a patient. But then also, [to] know how to interpret them, to either be able to treat them internally with the practice—if those particular treatments exist—or to refer them out, say to a partner with medical oncology if there's additional treatments they qualify for, but they may not have in house.

This transcript was AI generated and edited by human editors for clarity.

Related Videos
Mohamad Baker Berjaoui, MD, answers a question during a Zoom video interview
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Justin Dubin, MD, answers a question during a video interview
Phillip M. Pierorazio, MD, answers a question during a video interview
Michael Jenson, PA-C, answers a question during a Zoom video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.